C582286 | 1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea | ERCC5 mutant form results in increased susceptibility to 1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea | 26208482 |
C016403 | 2,4-dinitrotoluene | "2,4-dinitrotoluene affects the expression of ERCC5 mRNA" | 21346803 |
C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene affects the expression of ERCC5 mRNA" | 21346803 |
C572491 | 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol | 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol results in decreased expression of ERCC5 protein | 26194647 |
C472791 | 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid | 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of ERCC5 mRNA | 16788091 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ERCC5 mRNA" | 27188386 |
C013813 | 4-anisidine | 4-anisidine results in increased expression of ERCC5 mRNA | 12929121 |
C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in decreased expression of ERCC5 mRNA | 12419474 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ERCC5 mRNA" | 27188386 |
C499693 | 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one | 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one inhibits the reaction [ERCC5 gene SNP results in decreased susceptibility to Cisplatin] | 26338418 |
C499693 | 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one | 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one inhibits the reaction [[ERCC5 gene SNP results in decreased susceptibility to Cisplatin] which results in increased expression of ERCC5 protein] | 26338418|2633841 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of ERCC5 mRNA | 19770486 |
D000393 | Air Pollutants | Air Pollutants results in increased expression of ERCC5 protein | 28389379 |
D001151 | Arsenic | Arsenic results in increased expression of ERCC5 mRNA | 11134558 |
D001205 | Ascorbic Acid | [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC5 mRNA | 17917374 |
D001241 | Aspirin | Aspirin results in increased expression of ERCC5 mRNA | 11906190 |
C072019 | benzo(a)pyrene diolepoxide I | benzo(a)pyrene diolepoxide I results in increased expression of ERCC5 mRNA | 27694624 |
C072019 | benzo(a)pyrene diolepoxide I | benzo(a)pyrene diolepoxide I results in increased expression of ERCC5 protein | 27694624 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of ERCC5 mRNA | 27694624 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of ERCC5 protein | 19748547 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased mutagenesis of ERCC5 gene | 25435355 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of ERCC5 mRNA | 14625279|1977048 |
D001564 | Benzo(a)pyrene | [Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of ERCC5 mRNA] | 14625279 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ERCC5 mRNA" | 26238291 |
D004958 | Estradiol | Estradiol affects the expression of ERCC5 mRNA | 15721199 |
C006780 | bisphenol A | bisphenol A affects the expression of ERCC5 mRNA | 21786754 |
C006780 | bisphenol A | bisphenol A results in increased expression of ERCC5 mRNA | 24901218 |
C006780 | bisphenol A | bisphenol A affects the expression of ERCC5 mRNA | 25181051 |
D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in decreased expression of ERCC5 mRNA | 12419474 |
D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of ERCC5 mRNA | 26525392 |
D019256 | Cadmium Chloride | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of ERCC5 mRNA | 12634122 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of ERCC5 mRNA | 20883709 |
C023600 | chromic oxide | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of ERCC5 mRNA | 12634122 |
C017133 | chromous chloride | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of ERCC5 mRNA | 12634122 |
C057270 | cisplatin-DNA adduct | ERCC5 mRNA results in decreased abundance of cisplatin-DNA adduct | 21452186 |
D019327 | Copper Sulfate | Copper Sulfate results in decreased expression of ERCC5 mRNA | 19549813 |
C017160 | cypermethrin | cypermethrin results in increased expression of ERCC5 mRNA | 25569846 |
C004742 | daidzein | daidzein affects the expression of ERCC5 mRNA | 15721199 |
D003976 | Diazinon | Diazinon results in decreased expression of ERCC5 mRNA | 16539210 |
D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of ERCC5 mRNA | 21266533 |
D002945 | Cisplatin | 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one inhibits the reaction [ERCC5 gene SNP results in decreased susceptibility to Cisplatin] | 26338418 |
D002945 | Cisplatin | 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one inhibits the reaction [[ERCC5 gene SNP results in decreased susceptibility to Cisplatin] which results in increased expression of ERCC5 protein] | 26338418|2633841 |
D002945 | Cisplatin | ERCC5 gene SNP results in decreased susceptibility to Cisplatin | 26338418 |
D002945 | Cisplatin | [ERCC5 gene SNP results in decreased susceptibility to Cisplatin] which results in increased expression of ERCC5 protein | 26338418|2633841 |
D002945 | Cisplatin | ERCC5 mRNA results in decreased susceptibility to Cisplatin | 21452186 |
D002945 | Cisplatin | ERCC5 mutant form inhibits the reaction [RRM2 mutant form promotes the reaction [TP53 mutant form promotes the reaction [Cisplatin results in increased phosphorylation of H2AFX protein]]] | 21875941 |
D002945 | Cisplatin | PPP1R15A protein inhibits the reaction [[ERCC5 gene SNP results in decreased susceptibility to Cisplatin] which results in increased expression of ERCC5 protein] | 26338418|2633841 |
D002945 | Cisplatin | Cisplatin results in increased expression of ERCC5 mRNA | 25270620 |
D002945 | Cisplatin | Cisplatin results in increased expression of ERCC5 mRNA | 26739623 |
D002945 | Cisplatin | Lovastatin promotes the reaction [Cisplatin results in increased expression of ERCC5 mRNA] | 26739623 |
C121718 | dicyclanil | dicyclanil results in increased expression of ERCC5 mRNA | 15664270 |
D004041 | Dietary Fats | Dietary Fats results in decreased expression of ERCC5 mRNA | 18042831 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC5 mRNA | 17917374 |
D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of ERCC5 mRNA | 17854601 |
D004052 | Diethylnitrosamine | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of ERCC5 mRNA] | 17854601 |
D004054 | Diethylstilbestrol | Diethylstilbestrol affects the expression of ERCC5 mRNA | 15721199 |
C065180 | fluvastatin | [zoledronic acid co-treated with fluvastatin] results in increased expression of ERCC5 mRNA | 16996129 |
C069837 | fullerene C60 | fullerene C60 results in decreased expression of ERCC5 mRNA | 19167457 |
D005947 | Glucose | [INS protein co-treated with Glucose] results in decreased expression of ERCC5 mRNA | 22634610 |
D006861 | Hydrogen Peroxide | [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of ERCC5 protein | 18951874 |
D006918 | Hydroxyurea | Hydroxyurea results in increased expression of ERCC5 mRNA | 12929121 |
C056493 | imiquimod | imiquimod results in increased expression of ERCC5 mRNA | 21878529 |
C011890 | kojic acid | [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC5 mRNA | 17917374 |
C008261 | lead acetate | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of ERCC5 mRNA | 12634122 |
D008148 | Lovastatin | Lovastatin promotes the reaction [Cisplatin results in increased expression of ERCC5 mRNA] | 26739623 |
D008148 | Lovastatin | Lovastatin results in increased expression of ERCC5 mRNA | 26739623 |
D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased expression of ERCC5 mRNA | 23649840 |
D016685 | Mitomycin | Mitomycin results in increased expression of ERCC5 mRNA | 25270620 |
C028007 | nickel monoxide | nickel monoxide results in decreased expression of ERCC5 mRNA | 19167457 |
C025256 | nonylphenol | nonylphenol results in decreased expression of ERCC5 mRNA | 22982499 |
D017239 | Paclitaxel | Paclitaxel results in increased expression of ERCC5 mRNA | 12929121 |
D000073878 | Palm Oil | Palm Oil results in decreased expression of ERCC5 mRNA | 18042831 |
D052638 | Particulate Matter | Particulate Matter results in increased expression of ERCC5 mRNA | 24769257 |
C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate results in increased expression of ERCC5 mRNA | 20442190 |
D048789 | Phytoestrogens | Phytoestrogens affects the expression of ERCC5 mRNA | 15721199 |
C006253 | pirinixic acid | NCF1 protein promotes the reaction [pirinixic acid results in decreased expression of ERCC5 mRNA] | 17950772 |
C006253 | pirinixic acid | pirinixic acid results in decreased expression of ERCC5 mRNA | 17950772 |
C006253 | pirinixic acid | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of ERCC5 mRNA] | 17950772 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of ERCC5 mRNA | 23557933 |
C027373 | potassium chromate(VI) | [Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of ERCC5 mRNA] | 14625279 |
D011192 | Potassium Dichromate | [Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of ERCC5 mRNA] | 14625279 |
D011374 | Progesterone | Progesterone results in increased expression of ERCC5 mRNA | 23012394 |
D011794 | Quercetin | Quercetin results in decreased expression of ERCC5 mRNA | 21632981 |
C547185 | riccardin D | riccardin D results in increased expression of ERCC5 mRNA | 24069304 |
C078903 | seocalcitol | seocalcitol results in decreased expression of ERCC5 mRNA | 12040012 |
C017947 | sodium arsenite | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of ERCC5 mRNA | 12634122 |
C017947 | sodium arsenite | sodium arsenite results in decreased expression of ERCC5 mRNA | 16014739 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of ERCC5 mRNA | 20883709 |
D019311 | Staurosporine | Staurosporine affects the expression of ERCC5 mRNA | 15721199 |
C016766 | sulforafan | sulforafan results in increased expression of ERCC5 mRNA | 20442190 |
D013467 | Sulindac | Sulindac results in decreased expression of ERCC5 mRNA | 11906190 |
D043823 | Taxoids | ERCC5 gene SNP results in decreased susceptibility to Taxoids | 16981845 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of ERCC5 mRNA | 21570461 |
D013806 | Theophylline | [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of ERCC5 protein | 18951874 |
C523062 | thio-dimethylarsinate | thio-dimethylarsinate results in increased expression of ERCC5 mRNA | 27320638 |
D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ERCC5 mRNA" | 27188386 |
D014635 | Valproic Acid | Valproic Acid affects the expression of ERCC5 mRNA | 25979313 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of ERCC5 mRNA | 26272509 |
D001335 | Vehicle Emissions | Vehicle Emissions affects the methylation of ERCC5 gene | 25560391 |
C025643 | vinclozolin | vinclozolin results in increased expression of ERCC5 mRNA | 23034163 |
C108830 | Y 27632 | Y 27632 results in increased expression of ERCC5 mRNA | 20878077 |
C088658 | zoledronic acid | [zoledronic acid co-treated with fluvastatin] results in increased expression of ERCC5 mRNA | 16996129 |